BiotechTube
Home/Pipeline/AV-001 (Tie2 Receptor Agonist)

AV-001 (Tie2 Receptor Agonist)

Brain Injury Prevention in Hemodialysis Patients

Phase 1/2Active

Key Facts

Indication
Brain Injury Prevention in Hemodialysis Patients
Phase
Phase 1/2
Status
Active
Company
AnGes, AnGes

About AnGes

Japanese biotech developing gene therapies and biologics for cardiovascular and critical care conditions.

View full company profile

About AnGes

Japanese biotech developing gene therapies and biologics for cardiovascular and critical care conditions.

View full company profile

Therapeutic Areas

CardiovascularCritical CareRare Diseases